Osnat Rosen

876 total citations
40 papers, 516 citations indexed

About

Osnat Rosen is a scholar working on Molecular Biology, Neurology and Infectious Diseases. According to data from OpenAlex, Osnat Rosen has authored 40 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Neurology and 11 papers in Infectious Diseases. Recurrent topics in Osnat Rosen's work include Botulinum Toxin and Related Neurological Disorders (14 papers), Neurological disorders and treatments (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Osnat Rosen is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (14 papers), Neurological disorders and treatments (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Osnat Rosen collaborates with scholars based in Israel, United States and Latvia. Osnat Rosen's co-authors include Jacob Anglister, Michal Sharon, Ran Zichel, Liron Feldberg, Richard Pazdur, Atiqur Rahman, Lori M. Minasian, Richard L. Schilsky, Daniel Auclair and Brenda Mester and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Clinical Infectious Diseases.

In The Last Decade

Osnat Rosen

40 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osnat Rosen Israel 14 185 142 132 116 112 40 516
Michael A. Thomas United States 10 102 0.6× 139 1.0× 76 0.6× 70 0.6× 15 0.1× 18 380
Matthew Downs United States 6 196 1.1× 143 1.0× 54 0.4× 25 0.2× 10 0.1× 10 707
Toshikazu Miyakawa Japan 10 209 1.1× 405 2.9× 286 2.2× 104 0.9× 13 0.1× 20 628
Mamadi Yilla United States 6 195 1.1× 81 0.6× 167 1.3× 30 0.3× 46 0.4× 8 536
Andrew J. Sloane Australia 13 277 1.5× 289 2.0× 135 1.0× 30 0.3× 8 0.1× 15 826
Dominika Rudnicka United Kingdom 9 503 2.7× 196 1.4× 82 0.6× 66 0.6× 11 0.1× 10 954
Katja Spieß Denmark 14 172 0.9× 21 0.1× 177 1.3× 55 0.5× 10 0.1× 33 614
Kristina Cunningham United States 12 718 3.9× 85 0.6× 108 0.8× 18 0.2× 20 0.2× 17 955
Alec A. Desai United States 11 342 1.8× 74 0.5× 110 0.8× 327 2.8× 8 0.1× 24 567
Peggy Mérida France 12 160 0.9× 58 0.4× 85 0.6× 30 0.3× 16 0.1× 15 325

Countries citing papers authored by Osnat Rosen

Since Specialization
Citations

This map shows the geographic impact of Osnat Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osnat Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osnat Rosen more than expected).

Fields of papers citing papers by Osnat Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osnat Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osnat Rosen. The network helps show where Osnat Rosen may publish in the future.

Co-authorship network of co-authors of Osnat Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Osnat Rosen. A scholar is included among the top collaborators of Osnat Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osnat Rosen. Osnat Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madrer, Nimrod, Ofir Israeli, Liad Hinden, et al.. (2025). 5′LysTTT tRNA fragments support survival of botulinum-intoxicated neurons by blocking ferroptosis. 1–17. 1 indexed citations
2.
Tam, Joseph, et al.. (2025). Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. Journal of Neurochemistry. 169(8). e70187–e70187. 3 indexed citations
3.
Rosen, Osnat, Arik Makovitzki, Lilach Cherry, et al.. (2022). SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine. Journal of Virological Methods. 303. 114498–114498. 3 indexed citations
4.
Rosen, Osnat, Anat Zvi, Itai Glinert, et al.. (2022). Coupling immuno-magnetic capture with LC–MS/MS(MRM) as a sensitive, reliable, and specific assay for SARS-CoV-2 identification from clinical samples. Analytical and Bioanalytical Chemistry. 414(5). 1949–1962. 12 indexed citations
5.
Zvi, Anat, Osnat Rosen, Hagit Achdout, et al.. (2021). Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis. ACS Omega. 6(5). 3525–3534. 19 indexed citations
6.
Rosen, Osnat, et al.. (2021). A Rabbit Model for Prolonged Continuous Intravenous Infusion Via a Peripherally Inserted Central Catheter. Frontiers in Pharmacology. 12. 637792–637792. 2 indexed citations
7.
Rosen, Osnat, et al.. (2021). New approach for the rational selection of markers to identify botulinum toxins. Archives of Toxicology. 95(4). 1503–1516. 3 indexed citations
8.
Marciano, Daniele, et al.. (2020). Phosphorescent palladium-tetrabenzoporphyrin indicators for immunosensing of small molecules with a novel optical device. Talanta. 224. 121927–121927. 5 indexed citations
9.
Wang, Nianshuang, Osnat Rosen, Lingshu Wang, et al.. (2019). Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD. Cell Reports. 28(13). 3395–3405.e6. 41 indexed citations
10.
Rosen, Osnat, Olubukola M. Abiona, Portia Gough, et al.. (2018). A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry. Journal of Virological Methods. 265. 77–83. 7 indexed citations
11.
Rosen, Osnat, et al.. (2017). Optimization of SNAP-25-derived peptide substrate for improved detection of botulinum A in the Endopep-MS assay. Analytical Biochemistry. 528. 34–37. 3 indexed citations
12.
Rosen, Osnat, et al.. (2017). Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E. Scientific Reports. 7(1). 14859–14859. 15 indexed citations
13.
Rosen, Osnat, Liron Feldberg, Sigalit Gura, et al.. (2015). Early, Real-Time Medical Diagnosis of Botulism by Endopeptidase-Mass Spectrometry. Clinical Infectious Diseases. 61(12). e58–e61. 9 indexed citations
14.
Minasian, Lori M., Osnat Rosen, Daniel Auclair, et al.. (2014). Optimizing Dosing of Oncology Drugs. Clinical Pharmacology & Therapeutics. 96(5). 572–579. 70 indexed citations
15.
Rosen, Osnat, Liron Feldberg, Sigalit Gura, & Ran Zichel. (2014). Improved detection of botulinum type E by rational design of a new peptide substrate for endopeptidase–mass spectrometry assay. Analytical Biochemistry. 456. 50–52. 14 indexed citations
16.
Rosen, Osnat, et al.. (2013). The Receptor Binding Domain of Botulinum Neurotoxin Serotype A (BoNT/A) Inhibits BoNT/A and BoNT/E Intoxications In Vivo. Clinical and Vaccine Immunology. 20(8). 1266–1273. 13 indexed citations
17.
Rosen, Osnat & Jacob Anglister. (2009). Epitope Mapping of Antibody–Antigen Complexes by Nuclear Magnetic Resonance Spectroscopy. Methods in molecular biology. 524. 37–57. 18 indexed citations
18.
Rosen, Osnat, et al.. (2008). Correlated mutations at gp120 positions 322 and 440: Implications for gp120 structure. Proteins Structure Function and Bioinformatics. 71(3). 1066–1070. 5 indexed citations
19.
Rosen, Osnat, Abraham O. Samson, Michal Sharon, Susan Zolla‐Pazner, & Jacob Anglister. (2006). Response to Matters Arising. Structure. 14(4). 649–651. 5 indexed citations
20.
Kessler, Naama, Anat Zvi, Michal Sharon, et al.. (2003). Expression, purification, and isotope labeling of the Fv of the human HIV-1 neutralizing antibody 447-52D for NMR studies. Protein Expression and Purification. 29(2). 291–303. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Thomas Breakdown of academic impact, for papers by Matthew Downs Breakdown of academic impact, for papers by Toshikazu Miyakawa Breakdown of academic impact, for papers by Mamadi Yilla Breakdown of academic impact, for papers by Andrew J. Sloane Breakdown of academic impact, for papers by Dominika Rudnicka Breakdown of academic impact, for papers by Katja Spieß Breakdown of academic impact, for papers by Kristina Cunningham Breakdown of academic impact, for papers by Alec A. Desai Breakdown of academic impact, for papers by Peggy Mérida
Rankless by CCL
2026